Market Overview

The global blood bags market is experiencing healthy growth, driven by a surge in blood transfusion demand, technological innovations, expanding healthcare infrastructure in emerging economies, and enhanced regulatory standards. Valued at USD 312.6 million in 2024, the market is projected to nearly double to USD 637.2 million by 2033, backed by a compound annual growth rate (CAGR) of 7.38%—highlighting its promising trajectory.

Study Assumption Years

BASE YEAR: 2024
HISTORICAL YEAR: 2019–2024
FORECAST YEAR: 2025–2033

Blood Bags Market – Key Takeaways

• Market size & growth: From USD 312.6 million (2024) to USD 637.2 million (2033) at a 7.38% CAGR .
• Regional leader: North America holds the lion’s share, driven by established healthcare systems and strong regulatory environment .
• Product dominance: Single blood bags lead due to widespread usage in basic transfusion procedures.
• Application split: Collection bags dominate over transfer bags, supporting increased donation and processing activities.
• Material preference: PVC bags remain most popular, offering cost-efficiency, though PET bags are gaining traction for eco-friendliness.
• Capacity preference: 300 ml capacity blood bags lead, ideal for major surgeries and high-volume applications.
• Emerging momentum: Asia-Pacific showing rapid growth, fueled by healthcare infrastructure expansion and rising blood donation awareness .

Market Growth Factors

1. Surge in Blood Transfusion Demand

The escalating number of surgeries, trauma cases, and chronic illnesses—coupled with an aging global population—drives robust demand for efficient blood collection and storage solutions. As medical procedures become more complex and frequent, healthcare providers increasingly rely on single and multi-bag systems to handle diverse patient needs. Collection blood bags, which include anticoagulants for component separation, play a crucial role in maintaining steady blood inventories. IMARC cites these demands—across oncology, cardiology, neurology and emergency care—as key growth catalysts .

2. Technological Advancements & Regulatory Compliance

Innovation in bag materials (PVC alternatives, DEHP-free, PET) and safety features (RFID tracking, leak-resistant seals, leukocyte-reduction filters) enhances both performance and traceability. These advances not only reduce contamination risks and prolong shelf life but also ensure compliance with stringent safety regulations. Technology like RFID enables real-time inventory monitoring—a critical factor in North America and Europe—while greener materials align with global environmental mandates. Investment in R&D to meet regulatory demands is positively influencing market competitiveness and adoption .

3. Expansion of Healthcare Infrastructure in Emerging Economies

Emerging regions, especially Asia-Pacific, are witnessing substantial healthcare investment and infrastructure improvement. Governments are enabling large-scale blood donation campaigns, boosting supply chain mechanisms—from collection to transfusion. For example, in India, camps collecting thousands of units are underscoring the demand for quality blood bags. Local manufacturers expanding production reduce reliance on imports, opening new market avenues. This dynamic, along with increased hospital and blood bank penetration, sustains strong CAGR in the region .

Request for a sample copy of this report: https://www.imarcgroup.com/blood-bags-market/requestsample

Market Segmentation

By Product Type:

• Single Blood Bag: Designed for a single unit of blood.
• Double Blood Bag: Stores two units separately.
• Triple Blood Bag: Supports three distinct components.
• Quadruple Blood Bag: Holds four different blood units.
• Penta Blood Bag: Enables storage of five units/components.

By Application:

• Collection Blood Bag: Used during donor drives with anticoagulants.
• Transfer Blood Bag: Facilitates sterile movement between bags or to patients.

By End User:

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Blood Banks
• Others

By Material:

• Poly Vinyl Chloride Blood Bag: Flexible, durable, cost-effective.
• Polyethylene Terephthalate Blood Bag: Biocompatible, recyclable, safer.
• Others

By Capacity:

• 100 ml Blood Bag
• 150 ml Blood Bag
• 250 ml Blood Bag
• 300 ml Blood Bag
• 350 ml Blood Bag
• 400 ml Blood Bag
• 450 ml Blood Bag
• 500 ml Blood Bag

Breakup by Region:

• North America (United States, Canada)

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America (Brazil, Mexico, Others)

• Middle East and Africa

Regional Insights

North America is leading the charge, holding the largest share of the market. This dominance is supported by strong regulations, a widespread embrace of advanced materials and RFID technology, and a high volume of sophisticated medical procedures. Hospitals and blood banks are increasingly turning to innovative filtration and traceability systems, which are driving ongoing growth and deeper technology integration.

Recent Developments & News

The blood bags market is seeing a surge in innovation. In late 2021, Grifols introduced the ALBUTEIN FlexBag, an eco-friendly albumin solution that’s free from plasticizers. Then, in March 2022, Terumo launched its personalized TMCS brand aimed at boosting hospital efficiency and enhancing patient safety. More recently, Teleflex’s acquisition of Palette Life Sciences in July 2023 has expanded its urology offerings and sparked impressive double-digit revenue growth. Additionally, technological advancements like built-in leukocyte filters from Grifols and Macopharma are enhancing transfusion safety and minimizing immune risks.

Key Players

• AdvaCare Pharma
• BL Life Sciences Pvt. Ltd
• Demophorius Healthcare Ltd.
• Fresenius SE & Co. KGaA
• Grifols S.A.
• Haemonetics Corporation
• HLL Lifecare Limited
• Innvol Medical India Limited
• JMS Co. Ltd.
• Kawasumi Laboratories Inc.
• Maco Pharma International GmbH
• Mitra Industries Pvt. Ltd.
• Neomedic Limited
• Poly Medicure Ltd.
• Span Healthcare Private Limited
• Suru International Private Ltd.
• Teleflex Incorporated
• Terumo Corporation
• The Metric Company
• Troge Medical GmbH

Ask Analyst for Customization:  https://www.imarcgroup.com/request?type=report&id=2441&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us: 

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: +1-631-791-1145